MOTS-c is a mitochondrial-derived peptide (MDP) used mainly in research to treat metabolic disorders, enhance exercise capacity, and combat age-related decline. It functions as a signaling molecule to regulate insulin resistance, boost glucose metabolism in muscle tissue, reduce obesity, and improve cardiovascular function. It is grouped under the following drug class(es): Compounded peptides and Peptides. Its therapeutic use is listed as compounding pharmacy peptides. The directory classifies it as a under development API with a peptide source/manufacturing origin. Other names for this substance include UNII-A5CV6JFB78 and A5CV6JFB78. Its PubChem CID is 146675088.
Mots-c
| CAS No | 1627580-64-6 |
|---|---|
| Molecular Formula | C101H152N28O22S2 |
| Molecular Weight | 2174.6 g/mol |
| Synonyms | (4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-oxopentanoyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
MOTS-c is a mitochondrial-derived peptide (MDP) used mainly in research to treat metabolic disorders, enhance exercise capacity, and combat age-related decline.
The listed CAS number is 1627580-64-6.
The listed molecular formula is C101H152N28O22S2.
The listed molecular weight is 2174.6 g/mol.
The source lists UNII-A5CV6JFB78 and A5CV6JFB78.
Its therapeutic use is listed as compounding pharmacy peptides.